EFFICACY AND SAFETY OF CRIZOTINIB IN ADVANCED ALK-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC) RESULTS FROM A PHASE II GLOBAL TRIAL

作者： Carlos G Ferreira , C Barrios , Alice T Shaw , Yuankai Shi , Tommaso M De Pas

DOI:

关键词: